Fluticasone Propionate And Salmeterol Powder, Metered
Product Images NDC 0093-3607

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate And Salmeterol (NDC 0093-3607). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fp Chem Structure (Fluticasone Propionate Salmeterol Inhalation Powde 1)

FDA Label Image

Figure 8 (Fluticasone Propionate Salmeterol Inhalation Powde 10)

FDA Label Image

Teva Logo (Fluticasone Propionate Salmeterol Inhalation Powde 11)

FDA Label Image

Teva Logo (Fluticasone Propionate Salmeterol Inhalation Powde 12)

FDA Label Image

Figurr A (Fluticasone Propionate Salmeterol Inhalation Powde 13)

The text describes the features of a medical device, which includes a dose counter, a vent, a mouthpiece, and a yellow cap. It is most likely an inhaler or similar product used for administering medication.*

FDA Label Image

Figure B (Fluticasone Propionate Salmeterol Inhalation Powde 14)

This is a description of an inhaler that has 60 doses when full and is indicated as empty when it has no doses left.*

FDA Label Image

Figure C (Fluticasone Propionate Salmeterol Inhalation Powde 15)

FDA Label Image

Figure D (Fluticasone Propionate Salmeterol Inhalation Powde 16)

FDA Label Image

Breathe Out Image (Fluticasone Propionate Salmeterol Inhalation Powde 17)

FDA Label Image

Figure F (Fluticasone Propionate Salmeterol Inhalation Powde 18)

FDA Label Image

Figure G (Fluticasone Propionate Salmeterol Inhalation Powde 19)

FDA Label Image

Salmeterol Chem Structure (Fluticasone Propionate Salmeterol Inhalation Powde 2)

FDA Label Image

Figure H (Fluticasone Propionate Salmeterol Inhalation Powde 20)

FDA Label Image

Teva Logo (Fluticasone Propionate Salmeterol Inhalation Powde 21)

FDA Label Image

Ndc 0093-3607-82 (Carton)

This is a description of a medication called "Fluticasone Propionate and Salmeterol Inhalation Powder." The medication is meant for oral inhalation and includes a dose counter. The packaging indicates a net content of 0.45 g and 60 metered inhalations. The enclosed patient leaflet contains information on product use and potential side effects.*

FDA Label Image

113 Mcg/ 14 Mcg Carton (NDC 0093-3608-82)

This text describes a medication called "Fluticasone Propionate and Salmeterol Inhalation Powder" that is used for oral inhalation. It comes with a dose counter and provides 60 metered inhalations per 0.45g net contents. The user is directed to refer to the enclosed patent leaflet and instructions for use for information on product usage and handling.*

FDA Label Image

232 Mcg / 14 Mcg Carton (NDC 0093-3609-82)

This appears to be the packaging and labeling information for a medication called "Fluticasone Propionate and Salmeterol Inhalation Powder." It is for oral inhalation only, has a dose counter, and comes with a patient leaflet. The net contents are 0.45 g and there are 60 metered inhalations. The medication contains 232 mcg of fluticasone propionate and 14 mcg of salmeterol.*

FDA Label Image

Figure 1 (Fluticasone Propionate Salmeterol Inhalation Powde 3)

FDA Label Image

Figure 2 (Fluticasone Propionate Salmeterol Inhalation Powde 4)

FDA Label Image

Figure 3 (Fluticasone Propionate Salmeterol Inhalation Powde 5)

FDA Label Image

Figure 4 (Fluticasone Propionate Salmeterol Inhalation Powde 6)

This appears to be a table or chart containing information about different medications and their effectiveness in improving FEV (forced expiratory volume) over time. The medications listed are O FS MDPI, 05 & FS MDPI, FP MDPI, A FP MDP15S, and a placebo. The number of participants (N) in each group is also given. However, without additional context or clarification, it is difficult to provide a more detailed or specific description of the text.*

FDA Label Image

Figure 5 (Fluticasone Propionate Salmeterol Inhalation Powde 7)

FDA Label Image

Figure 6 (Fluticasone Propionate Salmeterol Inhalation Powde 8)

FDA Label Image

Figure 7 (Fluticasone Propionate Salmeterol Inhalation Powde 9)

This text represents a table showing the mean change in FEV (forced expiratory value) measured in liters. The table compares the change in FEV of different doses of FSMDPI and MDPI with a placebo over time. However, it is unclear what the units on the horizontal axis represent.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.